Registry of Fabry Disease - A Multicenter Observational Study

Completed

Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to compile a registry of patients with Fabry disease, an inherited metabolic disorder. In this disease, an enzyme called a-galactosidase A, which normally breaks down a lipid (fatty substance) called globotriaosylceramide (Gb3), is missing or does not function properly. As a result, Gb3 accumulates, causing problems with the kidneys, heart, nerves, and blood vessels. It is not known...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 June 2017.

13 Feb 2003 15 Feb 2003 Unavailable 3 Mar 2008 3 Mar 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

Not available